HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $524,000 | -5.2% | 4,559 | +3.9% | 0.00% | 0.0% |
| Q3 2019 | $553,000 | +76.7% | 4,386 | +69.2% | 0.00% | +100.0% |
| Q2 2019 | $313,000 | -33.8% | 2,592 | -52.1% | 0.00% | -50.0% |
| Q1 2019 | $473,000 | +133.0% | 5,414 | +167.8% | 0.00% | +100.0% |
| Q4 2018 | $203,000 | +534.4% | 2,022 | +614.5% | 0.00% | – |
| Q3 2018 | $32,000 | +28.0% | 283 | +2.2% | 0.00% | – |
| Q2 2018 | $25,000 | -69.1% | 277 | -75.2% | 0.00% | -100.0% |
| Q1 2018 | $81,000 | +22.7% | 1,115 | -1.7% | 0.00% | 0.0% |
| Q4 2017 | $66,000 | +29.4% | 1,134 | -0.8% | 0.00% | 0.0% |
| Q3 2017 | $51,000 | +6.2% | 1,143 | -6.1% | 0.00% | 0.0% |
| Q2 2017 | $48,000 | +2.1% | 1,217 | +4.2% | 0.00% | 0.0% |
| Q1 2017 | $47,000 | +2.2% | 1,168 | +1.2% | 0.00% | 0.0% |
| Q4 2016 | $46,000 | -19.3% | 1,154 | -26.6% | 0.00% | 0.0% |
| Q3 2016 | $57,000 | +18.8% | 1,572 | -7.0% | 0.00% | 0.0% |
| Q2 2016 | $48,000 | – | 1,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |